Sculptra® (Poly-L-lactic acid)

Posted in on

An approved injectable facial dermal (under skin) filler for the treatment of HIV-associated facial lipoatrophy (fat loss in the face). Access to Sculptra is funded under the Pharmaceutical Benefit Scheme (PBS – patient medicines cost subsidy scheme) for people with HIV with moderate to severe facial lipoatrophy. Your HIV doctor can authorise and provide you the PBS script for the subsidised cost of the product. A registered HIV-trained cosmetic physician will administer the Sculptra according to that physician’s practice fee schedule. These practitioners can set their own fee levels for administering the facial injections, by charging above the listed Medical Benefits Schedule (MBS) fee, which may increase your out of pocket expenses. However, some cosmetic practitioners may reduce their fees for PLHIV, or change the Medicare schedule fee only, lowering or removing your out-of pocket practitioner fees. Contact your state PLHIV community-based organisation for more details and how to access this treatment and/or to ascertain whether there is registered cosmetic practitioner in your location or area.